Several financial institutions, including TD Cowen, Guggenheim, Citi, William Blair, and Wells Fargo, have named their top biotechnology stock picks for 2026. Some outlets report specific companies being chosen, such as Cytokinetics and Agios, while others list multiple top picks without specifying the companies. The exact top pick from TD Cowen is reported to be Agios by one outlet, but this is not consistently stated across all reports.